Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cardiol Therapeutics (TSE:CRDL)
TSX:CRDL
Cardiol Therapeutics (CRDL) Ownership Overview
5.34% Insiders
0.06% Mutual Funds
6.52% Other Institutional Investors
1.49% ETFs
86.58% Public Companies and Individual Investors
The ownership structure of Cardiol Therapeutics (TSE:CRDL) stock is a mix of institutional, retail, and individual investors. Approximately 8.07% of the company’s stock is owned by Institutional Investors, 5.34% is owned by Insiders, and 86.58% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Dec 27, 2024 | Guillermo Torre Chairman,director | xxxxxxxxxxxxx | $21721 |
| Dec 25, 2024 | Andrew Warwick Hamer Chief Medical Officer | xxxxxxxxxxxxx | $24727 |
| Dec 24, 2024 | Guillermo Torre Chairman,director | xxxxxxxxxxxxx | $28333 |
| Dec 19, 2024 | Peter Pekos Non Executive,director | xxxxxxxxxxxxx | $49968 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,244,500 | Insider | 1.53% | 1,508,334 | |
| 1,012,080 | Insider | 1.24% | 1,226,641 | |
| 882,488 | Institution | 1.08% | 1,069,575 | |
| 840,580 | Insider | 1.03% | 1,018,783 | |
| 466,613 | Insider | 0.57% | 565,535 | |
| 283,253 | Institution | 0.35% | 343,303 | |
| 259,309 | Insider | 0.32% | 314,283 | |
| 142,500 | Insider | 0.17% | 172,710 | |
| 135,900 | Insider | 0.17% | 164,711 | |
| 120,000 | Insider | 0.15% | 145,440 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 52,435 | Institution | 0.06% | 63,551 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 882,488 | Institution | 1.08% | 1,094,285 | |
| 53,727 | Institution | 0.07% | 94,022 |
FAQ
Who Owns Cardiol Therapeutics (TSE:CRDL)?
According to the latest TipRanks data, approximately 6.52% of the company's stock is held by institutional investors, 5.34% is held by insiders, and 86.58% is held by retail investors.
What percentage of Cardiol Therapeutics (TSE:CRDL) stock is held by institutional investors?
According to the latest TipRanks data, approximately 6.52% of Cardiol Therapeutics (TSE:CRDL) stock is held by institutional investors.
What percentage of Cardiol Therapeutics (TSE:CRDL) stock is held by retail investors?
According to the latest TipRanks data, approximately 86.58% of Cardiol Therapeutics (TSE:CRDL) stock is held by retail investors.
Who owns the most shares of Cardiol Therapeutics (TSE:CRDL)?
David Elsley owns the most shares of Cardiol Therapeutics (TSE:CRDL).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.